HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficiency of combined therapy with impaza and type 5 phosphodiesterase inhibitors in prophylactics of posttraumatic erectile dysfunction.

Abstract
The use of combined pharmacotherapy with impaza and type 5 phosphodiesterase inhibitors helps to prevent and/or considerably reduce the risk of posttraumatic erectile dysfunction in men with traumas and strictures of the urethra. This therapy is indicated at early terms after trauma of the urethra for prophylactics of erectile dysfunction.
AuthorsKh S Ibishev
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 148 Issue 2 Pg. 322-4 (Aug 2009) ISSN: 1573-8221 [Electronic] United States
PMID20027359 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antibodies
  • IMPAZA
  • Phosphodiesterase Inhibitors
Topics
  • Antibodies (therapeutic use)
  • Erectile Dysfunction (drug therapy, etiology)
  • Humans
  • Male
  • Phosphodiesterase Inhibitors (therapeutic use)
  • Treatment Outcome
  • Urethra (injuries)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: